O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$126M 1.33%
13,791,178
+386,856
27
$123M 1.29%
3,183,600
-476,000
28
$122M 1.29%
4,344,588
-2,108
29
$105M 1.1%
2,653,874
+138,900
30
$105M 1.1%
812,000
+574,000
31
$100M 1.06%
7,400,000
32
$95.8M 1.01%
104,200
33
$88.9M 0.94%
11,519,700
+1,869,800
34
$88.5M 0.93%
2,094,500
+83,000
35
$84.4M 0.89%
1,023,200
+874,200
36
$84.2M 0.89%
1,912,000
+147,300
37
$80.9M 0.85%
2,753,425
+514,600
38
$80.2M 0.84%
1,309,000
+47,000
39
$76.2M 0.8%
+5,258,450
40
$72.9M 0.77%
4,557,740
+191,000
41
$72.3M 0.76%
1,487,000
42
$62.1M 0.65%
+339,700
43
$59.5M 0.63%
2,175,857
44
$57.5M 0.61%
531,800
+239,800
45
$51.9M 0.55%
6,095,647
46
$51.6M 0.54%
300,371
+49,400
47
$50.7M 0.53%
+981,200
48
$50M 0.53%
666,299
+78,000
49
$48.9M 0.51%
2,897,938
+1
50
$46M 0.48%
335,500
+53,500
1
2
3 4 5